Protocol
More milk, yogurt and cheese for older adults in care homes
In a cluster trial across 56 Australian care homes, adding milk, yogurt and cheese to bring calcium and protein intake up to recommended levels cut fractures by 33%, hip fractures by 46% and falls by 11% over two years.
Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →
At a glance
In a large study of 56 care homes in Australia, half the homes gave residents extra milk, yogurt and cheese each day. Over two years, those residents had a third fewer broken bones and about half as many broken hips. They fell a little less. Deaths did not change. Only one trial has shown this so far.
- What was measured
- Fractures and falls over two years.
- How big
- All fractures were 33% lower (121 against 203) with added dairy foods.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 34670754.
- Who it applies to
- Older adults living in care homes.
- Safety
- No harms reported; serum lipids not worsened in a follow-up analysis.
- Compared with
- Usual care-home menus.
- Certainty
- Grade C, resting on: One large cluster randomized trial with fracture outcomes.
- What would change this grade
- Could rise to B with: Cluster randomized trial of dairy foods. Who: Care-home residents outside Australia. Measured: Fractures. Length: At least 2 years.
- Cost
- No price recorded yet.
- Sources
- 1 study cited on this record, listed under Sources.
- For clinicians
- A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
In a cluster trial across 56 Australian care homes, adding milk, yogurt and cheese to bring calcium and protein intake up to recommended levels cut fractures by 33%, hip fractures by 46% and falls by 11% over two years. Deaths did not change.
Why this letter
Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Grade C on fractures. A cluster randomized trial in 56 care homes found fewer fractures, including hip fractures, when dairy foods raised calcium and protein intake to recommended levels (Iuliano et al., 2021; PMID 34670754).
WHY NOT Bunder Rule 06 a single positive trial without independent replication The same finding reproduced by a separate research group. A result seen once can be chance or bias; a replicated one is harder to explain away. is a C; later papers from the same trial do not count as replication.
WHAT THIS GRADE DOES NOT COVERpeople living at home, calcium tablets, and dairy for heart disease or other outcomes. It also does not cover dairy added for people who already eat enough calcium and protein, since the trial raised intake only up to recommended levels.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Who responds: this record's trial reading reports no subgroup that identifies who responds.
Evidence notes: randomized trial
Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Fractures (hard)
Last reviewed: November 2026
The trial that would change this grade.
A positive trial of this shape, supported by further trials, would move this entry to B.
Why the current trials fall short
An independent replication would carry it to B.
ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Dairy Products among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.
Search recruiting studies of Dairy Products on ClinicalTrials.gov
Dose, form and timing
Not applicable; the outcome is fractures.
Safety
No safety data. Each caution on this record, sorted by what it rests on.
None recorded.
None recorded.
None recorded.
None recorded.
No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.
Grade history
How this letter has changedLatest: No. 464 · November 2026 · First graded.
New record in the gap-report batch. In a cluster trial across 56 Australian care homes, adding milk, yogurt and cheese to bring calcium and protein intake up to recommended levels cut fractures by 33%, hip fractures by 46% and falls by 11% over two years. Deaths did not change.PMID 34670754
Every change to a letter on this site is dated and published. The full evidence log →
Sources
- Citations
- Every paper cited on this page is matched to its PubMed record on every build.
- Retractions
- None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
- Read against the papers
- November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
- Outside review
- Not yet done. No reviewer outside EBL has checked this record.
What each of these checks can and cannot show: evidence integrity.
The evidence, in fullOne paper, linked to its PubMed record.
Iuliano et al. (BMJ, 2021; PMID 34670754): cluster randomized trial, 27 intervention and 29 control care homes in Australia, 7,195 residents, mean age about 86; all fractures 121 against 203 (HR 0.67, 95% CI 0.48 to 0.93), hip fractures 42 against 93 (HR 0.54), falls 1,879 against 2,423 (HR 0.89); mortality unchanged.
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
(dairy[tiab] OR milk[tiab]) AND fracture*[tiab] AND randomized controlled trial[pt]PubMed watch: does a new study change the grade? (nothing new)
No new paper matching the search behind this grade has been added to PubMed since November 2026.
Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.
For each trial behind a letter on this page, the funding its PubMed record lists. "No funder" means PubMed lists none, not that the trial had no funding.
- Iuliano et al., 2021, BMJ (PMID 34670754): PubMed lists no funder for this trial. The PubMed record carries a competing-interest statement.
Disclosure
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
© Evidence Based Longevity, Inc. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →